BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 34897704)

  • 21. Adjuvant therapy in melanoma.
    Mohr P; Weichenthal M; Hauschild A
    Onkologie; 2003 Jun; 26(3):227-33. PubMed ID: 12845206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single or dual immune checkpoint inhibitor as adjuvant therapy in advanced melanoma.
    Fukumoto T; Horita N
    Eur J Cancer; 2021 Apr; 147():140-141. PubMed ID: 33662688
    [No Abstract]   [Full Text] [Related]  

  • 23. Which adjuvant treatment for patients with BRAF
    Funck-Brentano E; Malissen N; Roger A; Lebbé C; Deilhes F; Frénard C; Dréno B; Meyer N; Grob JJ; Tétu P; Saiag P
    Ann Dermatol Venereol; 2021 Sep; 148(3):145-155. PubMed ID: 33579557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune checkpoint inhibitors in melanoma in the metastatic, neoadjuvant, and adjuvant setting.
    Herrscher H; Robert C
    Curr Opin Oncol; 2020 Mar; 32(2):106-113. PubMed ID: 31876547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Educational Review: Neoadjuvant Approaches to Melanoma.
    Sharon CE; Karakousis GC
    Ann Surg Oncol; 2022 Dec; 29(13):8492-8500. PubMed ID: 35849287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining BRAF/MEK Inhibitors with Immunotherapy in the Treatment of Metastatic Melanoma.
    Ziogas DC; Konstantinou F; Bouros S; Theochari M; Gogas H
    Am J Clin Dermatol; 2021 May; 22(3):301-314. PubMed ID: 33765322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous Melanoma - A Review of Systemic Therapies.
    Lee KA; Nathan P
    Acta Derm Venereol; 2020 Jun; 100(11):adv00141. PubMed ID: 32346745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Operable Melanoma: Screening, Prognostication, and Adjuvant and Neoadjuvant Therapy.
    Tarhini AA; Lorigan P; Leachman S
    Am Soc Clin Oncol Educ Book; 2017; 37():651-660. PubMed ID: 28561661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous melanoma: interferon alpha adjuvant therapy for patients at high risk for recurrent disease.
    Lens M
    Dermatol Ther; 2006; 19(1):9-18. PubMed ID: 16405565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of adjuvant therapy in melanoma management.
    Barth A; Morton DL
    Cancer; 1995 Jan; 75(2 Suppl):726-34. PubMed ID: 7805001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant systemic therapy in high-risk melanoma.
    Blankenstein SA; van Akkooi ACJ
    Melanoma Res; 2019 Aug; 29(4):358-364. PubMed ID: 30896556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adjuvant therapy of surgically removed stage I melanoma].
    Weil M; Borel C; Rixe O; Antoine E; Auclerc G; Banzet P; Khayat D
    Ann Dermatol Venereol; 1995; 122(5):315-8. PubMed ID: 8572473
    [No Abstract]   [Full Text] [Related]  

  • 33. Current therapy of cutaneous melanoma.
    Mays SR; Nelson BR
    Cutis; 1999 May; 63(5):293-8. PubMed ID: 10349545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Finding the right combination for neoadjuvant therapy in high-risk, stage III melanoma.
    Amaria R; Caffrey M
    Am J Manag Care; 2019 Feb; 25(2 Spec No.):SP43-SP44. PubMed ID: 30776211
    [No Abstract]   [Full Text] [Related]  

  • 35. Recent advances in melanoma systemic therapy. BRAF inhibitors, CTLA4 antibodies and beyond.
    Menzies AM; Long GV
    Eur J Cancer; 2013 Oct; 49(15):3229-41. PubMed ID: 23870385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The usefulness of neo- and adjuvant therapy in the treatment of cutaneous melanoma].
    Dzhabarov FR; Rozenko LIa; Pozdniakova VV; Nepomniashchaia EM
    Vopr Onkol; 2011; 57(4):521-4. PubMed ID: 22191247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel adjuvant options for cutaneous melanoma.
    Dimitriou F; Long GV; Menzies AM
    Ann Oncol; 2021 Jul; 32(7):854-865. PubMed ID: 33771664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy for Melanoma.
    Moyers JT; Glitza Oliva IC
    Adv Exp Med Biol; 2021; 1342():81-111. PubMed ID: 34972963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Systemic treatment of melanoma. Current clinical trials].
    Hauschild A; Rass K; Tilgen W
    Hautarzt; 2008 Jun; 59(6):484-91. PubMed ID: 18478195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updates in adjuvant systemic therapy for melanoma.
    Kwak M; Farrow NE; Salama AKS; Mosca PJ; Hanks BA; Slingluff CL; Beasley GM
    J Surg Oncol; 2019 Jan; 119(2):222-231. PubMed ID: 30481375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.